Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effect of oral neflaMapimod on motor recovery after acute ischaemic stroke is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neflamapimod (neflamapimod)

Snippet

Sponsor: EIP Pharma Inc | Conditions: Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke | Phase 2 | Status: RECRUITING